New Therapeutic Approved by FDA to Treat Breast Cancer

Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in combination with any aromatase inhibitor for initial treatment of postmenopausal women with a hormone receptor (HR)–positive, HER2-negative, advanced breast cancer.

Read More

Why Shouldn’t I Tan Indoors?

Before you try to banish the winter blues by adding some color to your skin with a trip to the tanning salon, remember that exposure to ultraviolet (UV) light from indoor tanning beds, sunlamps, and tanning booths increases your risk of developing skin cancer.

Read More